Abstract
Background
Esophagectomy is regarded as one of the optimal treatments for resectable esophageal cancer. However, the impact of surgical approach on the long-term prognosis of esophageal cancer remains controversial. This study attempted to compare the long-term survival outcomes of patients receiving left and right thoracic esophagectomy for esophageal cancer.
Methods
A total of 985 patients underwent esophagectomy (including 453 left and 532 right thoracic approach) for esophageal cancer in Henan Cancer Hospital from January 2015 to December 2016 were enrolled. Their 5 year overall survival (OS) and disease-free survival (DFS) were retrospectively collected. Cox regression was performed to compare OS and DFS in patients who underwent left and right thoracic esophagectomy. Propensity score matching (PSM) analysis was used to balance confounding factors.
Results
The 5 year OS rates were 60.21% in the left and 51.60% in the right thoracic esophagectomy, respectively (P = 0.67). The 5 year DFS rates were 56.73% in the left and 47.93% and in the right thoracic esophagectomy, respectively (P = 0.36). Cox regression analysis showed there was no significant difference in long-term survival between patients with left and right surgical access (OS: HR = 0.95, 95% CI 0.77–1.18; DFS: HR = 0.91, 95% CI 0.74–1.12). In the cohort of patients obtained by PSM, Cox regression analysis yielded the similar results.
Conclusion
For patients with resectable esophageal cancer, the surgical treatment through left thoracic approach can achieve the same long-term survival outcomes as the right thoracic approach.
Similar content being viewed by others
Data availability
The data underlying this article were provided by the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital under licence. Data will be shared on request to the corresponding author with permission of the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital.
Abbreviations
- CI:
-
Confidence interval
- DFS:
-
Disease-free survival
- HR:
-
Hazard ratios
- M:
-
Mean
- OS:
-
Overall survival
- Pathological N stage:
-
Pathological lymph-node stage
- PSM:
-
Propensity score matching
- Pathological T stage:
-
Pathological tumor stage
- SD:
-
Standardized deviation
- SMD:
-
Standardized mean difference
References
Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS et al (2019) Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 17:855–883
Bogoevski D, Onken F, Koenig A, Kaifi JT, Schurr P, Sauter G, Izbicki JR, Yekebas EF (2008) Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 247:633–641
Boshier PR, Anderson O, Hanna GB (2011) Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: a meta-analysis. Ann Surg 254:894–906
Chen D, Hu Y, Chen Y, Hu J, Wen Z (2020) Comparison of outcomes between mckeown and sweet esophagectomy in the elderly patients for esophageal squamous cell carcinoma: a propensity score-matched analysis. Cancer Control 27:1073274820904700
Jung MK, Schmidt T, Chon SH, Chevallay M, Berlth F, Akiyama J, Gutschow CA, Mönig SP (2020) Current surgical treatment standards for esophageal and esophagogastric junction cancer. Ann N Y Acad Sci 1482:77–84
Lagergren J, Mattsson F, Lagergren P (2016) Weekday of esophageal cancer surgery and its relation to prognosis. Ann Surg 263:1133–1137
Li B, Xiang J, Zhang Y, Li H, Zhang J, Sun Y, Hu H, Miao L, Ma L, Luo X (2015) Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial. JAMA Surg 150:292–298
Li C, Ge N, Shen Y, Jiao W (2017) Exclusive right thoracic approach for esophagus surgery. Thorac Cancer 8:543–545
Li B, Hu H, Zhang Y, Zhang J, Miao L, Ma L, Luo X, Zhang Y, Ye T, Li H, Zhou J, Li Y, Shen L, Zhao K, Fan M, Zhu Z, Wang J, Xu J, Deng Y, Lu Q, Jia H, Cheng X, Li H, Zhang Y, Li C, Pan Y, Liu S, Hu H, Shao L, Sun Y, Xiang J, Chen H (2018) Extended right thoracic approach compared with limited left thoracic approach for patients with middle and lower esophageal squamous cell carcinoma: three-year survival of a prospective, randomized, open-label trial. Ann Surg 267:826–832
Li S, Chen H, Man J, Zhang T, Yin X, He Q, Yang X, Lu M (2021) Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years. Cancer Med 10:1889–1899
Li R, Sun J, Wang T, Huang L, Wang S, Sun P, Yu C (2022) Comparison of secular trends in esophageal cancer mortality in china and japan during 1990–2019: an age-period-cohort analysis. Int J Environ Res Public Health 19:10302
Ma J, Zhan C, Wang L, Jiang W, Zhang Y, Shi Y, Wang Q (2014) The sweet approach is still worthwhile in modern esophagectomy. Ann Thorac Surg 97:1728–1733
Ma Q, Liu W, Long H, Rong T, Zhang L, Lin Y, Ma G (2015) Right versus left transthoracic approach for lymph node-negative esophageal squamous cell carcinoma. J Cardiothorac Surg 10:1–7
Mao Y, He J, Xue Q, Shao K, Su K, Li N, Tan F, Zhou J (2013) Nationwide speaking tour of standardized diagnosis and treatment for esophageal cancer Zhonghua wei Chang wai ke za zhi. Chin J Gastroint Surg. 16:801–804
Mertens AC, Kalff MC, Eshuis WJ, Van Gulik TM, Van Berge Henegouwen MI, Gisbertz SS (2021) Transthoracic versus transhiatal esophagectomy for esophageal cancer: a nationwide propensity score-matched cohort analysis. Ann Surg Oncol 28:175–183
Situ D, Wang J, Lin P, Long H, Zhang L, Rong T, Ma G (2013) Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma? J Thorac Cardiovasc Surg 146:45–51
Suo C, Yang Y, Yuan Z, Zhang T, Yang X, Qing T, Gao P, Shi L, Fan M, Cheng H, Lu M, Jin L, Chen X, Ye W (2019) Alcohol intake interacts with functional genetic polymorphisms of aldehyde dehydrogenase (ALDH2) and alcohol dehydrogenase (ADH) to increase esophageal squamous cell cancer risk. J Thorac Oncol 14:712–725
van der Schaaf M, Johar A, Wijnhoven B, Lagergren P, Lagergren J (2015) Extent of lymph node removal during esophageal cancer surgery and survival. J Natl Cancer Inst 107:998
Wang Z-Q, Wang W-P, Yuan Y, Hu Y, Peng J, Wang Y-C, Chen L-Q (2016) Left thoracotomy for middle or lower thoracic esophageal carcinoma: still Sweet enough? J Thorac Dis 8:3187
Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW (2007) An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 245:717–725
Yang HX, Hou X, Liu QW, Zhang LJ, Liu JG, Lin P, Fu JH (2012) Tumor location does not impact long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China. Ann Thorac Surg 93:1861–1866
Yang CK, Teng A, Lee DY, Rose K (2015) Pulmonary complications after major abdominal surgery: National surgical quality improvement program analysis. J Surg Res 198:441–449
Yang D, Mao YS, He J, Gao SG, Sun KL, Mu JW, Xue Q, Wang DL, Gao YS, Zhao J, Liu XY, Fang DK, Li J, Wang YG, Zhang LZ, Huang JF, Wang B (2018) Long-term survival of the middle and lower thoracic esophageal cancer patients after surgical treatment through left or right thoracic approach. J Thorac Dis 10:2648–2655
Zheng Y, Li Y, Liu X, Zhang R, Sun H, Xing W (2020) Right compared with left thoracic approach esophagectomy for patients with middle esophageal squamous cell carcinoma. Front Oncol 10:536842
Acknowledgements
The authors sincerely acknowledge the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital for their support. We also gratefully thank all the research participants who gave their valuable time in this project.
Funding
The authors declare that no funds, grants, or other supports were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by XJ, YY, XX, PC, and YZ. The first draft of the manuscript was written by YY and XX. The manuscript was reviewed and revised by YY, XJ, XS, CY, and JF, and all authors commented on the previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
The study was performed following the Declaration of Helsinki set of principles. All data collection and analysis in this study were reviewed and approved by the Ethics Committee of Zhengzhou University (ZZUIRB2022-99). Informed written consent was obtained from each patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yang, Y., Xin, X., Chen, P. et al. Left compared with right thoracic approach thoracotomy in esophageal cancer: a retrospective cohort study. J Cancer Res Clin Oncol 149, 8289–8296 (2023). https://doi.org/10.1007/s00432-023-04765-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-023-04765-4